In the context of cancer, several studies have been published indicating that overexpression of Adora1 (adenosine A1 receptor) promotes the malignant progression of colorectal, renal, and breast cancers, as well as glioblastomas and leukemias (69). Here, ADORA1 is linked to breast carcinoma.